<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01756040</url>
  </required_header>
  <id_info>
    <org_study_id>HP-00049647</org_study_id>
    <secondary_id>R34AT006945-01</secondary_id>
    <nct_id>NCT01756040</nct_id>
  </id_info>
  <brief_title>Intestinal Permeability in Preterm Infants</brief_title>
  <acronym>IPPI</acronym>
  <official_title>Gut Permeability in Very Low Birth Weight Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Maryland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Maryland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Necrotizing enterocolitis (NEC) is a life-threatening, gastrointestinal emergency
      characterized by increased intestinal permeability, affects approximately 7 to 10% of infants
      &lt;1500 g birthweight, and typically occurs within 7 to 14 days of birth. Mortality is as high
      as 30-50%. Prematurity is the greatest risk factor for the development of NEC due to the
      physiological immaturity of the gastrointestinal tract and altered or abnormal gut
      microbiota. Several studies have demonstrated that the initiation of an intense systemic and
      local inflammatory cascade leads to intestinal necrosis. The human intestine is lined by a
      single layer of cells exquisitely responsive to multiple stimuli and is populated by a
      complex climax community of microbial partners. Under normal circumstances, these intestinal
      cells form a tight but selective barrier to &quot;friends and foes&quot;: microbes and most
      environmental substances are held at bay, but nutrients are absorbed efficiently. Epithelial
      barrier integrity is itself dynamic and matures over time starting soon after birth, though
      the mechanisms regulating dynamic permeability are poorly understood. Low birth weight,
      prematurity, and early postnatal age are associated with a leaky gut. Although intestinal
      permeability is higher at birth in preterm than term infants, there is usually rapid
      maturation of the intestinal barrier over the first few days of life in both populations. The
      investigators hypothesize that increased levels of measures of intestinal permeability (serum
      zonulin, urine lactulose/rhamnose (LA/Rh), and fecal alpha1- antitrypsin will identify
      infants at high risk for NEC. The purpose of the study is to determine whether measurement of
      intestinal permeability in serum will correlate with other markers of intestinal barrier
      leakiness measured in urine (LA/Rh) and stool (alpha-1 antitrypsin. If there is good
      correlation, then zonulin or serum rhamnose may be a useful measure to identify preterm
      babies at risk for NEC.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 2013</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intestinal permeability</measure>
    <time_frame>18 months</time_frame>
    <description>To develop a 'natural history' metabolic and microbiota profile, as well as examine if an 'index' of clinical indicators that monitor increased levels of intestinal permeability [serum zonulin; urine LA/Rh, fecal alpha1-antitrypsin, and possibly toll-like receptor 4 (TLR4, single nucleotide polymorphisms (SNPs) will identify very low birth weight(VLBW)neonates at high risk of NEC</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Prematurity</condition>
  <condition>Intestinal Permeability</condition>
  <arm_group>
    <arm_group_label>Lactulose - rhamnose solution</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Preterm Infants age 24-32 weeks gestation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lactulose -rhamnose solution</intervention_name>
    <description>Measurement of intestinal permeability by use of mon- digestible sugars known not to cross the intestinal barrier in normal healthy intestinal tissue</description>
    <arm_group_label>Lactulose - rhamnose solution</arm_group_label>
    <other_name>dual sugar solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &lt; 4 days

          -  Gestational age 24-32 weeks

        Exclusion criteria:

          -  Nonviable or planned withdrawal of care

          -  Significant GI dysfunction (e.g. heme-positive stools, abdominal distension (girth &gt;2
             cm baseline), or bilious emesis/aspirates.

          -  Triplet or higher order multiple

          -  Severe asphyxia

          -  Lethal chromosome abnormalities

          -  Cyanotic congenital heart disease

          -  Intestinal atresia or perforation

          -  Abdominal wall defects

          -  Known galactosemia or other galactose intolerance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>4 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alessio Fasano, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rose M Viscardi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Maryland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Fasano A. Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall. Am J Pathol. 2008 Nov;173(5):1243-52. doi: 10.2353/ajpath.2008.080192. Epub 2008 Oct 2.</citation>
    <PMID>18832585</PMID>
  </reference>
  <reference>
    <citation>Bjarnason I. Intestinal permeability. Gut. 1994 Jan;35(1 Suppl):S18-22. Review.</citation>
    <PMID>8125384</PMID>
  </reference>
  <reference>
    <citation>van Wijck K, Bessems BA, van Eijk HM, Buurman WA, Dejong CH, Lenaerts K. Polyethylene glycol versus dual sugar assay for gastrointestinal permeability analysis: is it time to choose? Clin Exp Gastroenterol. 2012;5:139-50. doi: 10.2147/CEG.S31799. Epub 2012 Jul 19.</citation>
    <PMID>22888267</PMID>
  </reference>
  <reference>
    <citation>van Wijck K, Verlinden TJ, van Eijk HM, Dekker J, Buurman WA, Dejong CH, Lenaerts K. Novel multi-sugar assay for site-specific gastrointestinal permeability analysis: a randomized controlled crossover trial. Clin Nutr. 2013 Apr;32(2):245-51. doi: 10.1016/j.clnu.2012.06.014. Epub 2012 Aug 11.</citation>
    <PMID>22892368</PMID>
  </reference>
  <reference>
    <citation>Beach RC, Menzies IS, Clayden GS, Scopes JW. Gastrointestinal permeability changes in the preterm neonate. Arch Dis Child. 1982 Feb;57(2):141-5.</citation>
    <PMID>7065710</PMID>
  </reference>
  <reference>
    <citation>Piena-Spoel M, Albers MJ, ten Kate J, Tibboel D. Intestinal permeability in newborns with necrotizing enterocolitis and controls: Does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition? J Pediatr Surg. 2001 Apr;36(4):587-92.</citation>
    <PMID>11283883</PMID>
  </reference>
  <reference>
    <citation>Rouwet EV, Heineman E, Buurman WA, ter Riet G, Ramsay G, Blanco CE. Intestinal permeability and carrier-mediated monosaccharide absorption in preterm neonates during the early postnatal period. Pediatr Res. 2002 Jan;51(1):64-70.</citation>
    <PMID>11756641</PMID>
  </reference>
  <reference>
    <citation>Albers MJ, Steyerberg EW, Hazebroek FW, Mourik M, Borsboom GJ, Rietveld T, Huijmans JG, Tibboel D. Glutamine supplementation of parenteral nutrition does not improve intestinal permeability, nitrogen balance, or outcome in newborns and infants undergoing digestive-tract surgery: results from a double-blind, randomized, controlled trial. Ann Surg. 2005 Apr;241(4):599-606.</citation>
    <PMID>15798461</PMID>
  </reference>
  <reference>
    <citation>Piena M, Albers MJ, Van Haard PM, Gischler S, Tibboel D. Introduction of enteral feeding in neonates on extracorporeal membrane oxygenation after evaluation of intestinal permeability changes. J Pediatr Surg. 1998 Jan;33(1):30-4.</citation>
    <PMID>9473094</PMID>
  </reference>
  <reference>
    <citation>Malagon I, Onkenhout W, Klok M, van der Poel PF, Bovill JG, Hazekamp MG. Gut permeability in neonates after a stage 1 Norwood procedure. Pediatr Crit Care Med. 2005 Sep;6(5):547-9.</citation>
    <PMID>16148815</PMID>
  </reference>
  <reference>
    <citation>Noone C, Menzies IS, Banatvala JE, Scopes JW. Intestinal permeability and lactose hydrolysis in human rotaviral gastroenteritis assessed simultaneously by non-invasive differential sugar permeation. Eur J Clin Invest. 1986 Jun;16(3):217-25.</citation>
    <PMID>3089818</PMID>
  </reference>
  <reference>
    <citation>van Elburg RM, Fetter WP, Bunkers CM, Heymans HS. Intestinal permeability in relation to birth weight and gestational and postnatal age. Arch Dis Child Fetal Neonatal Ed. 2003 Jan;88(1):F52-5.</citation>
    <PMID>12496227</PMID>
  </reference>
  <reference>
    <citation>Catassi C, Bonucci A, Coppa GV, Carlucci A, Giorgi PL. Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J Pediatr Gastroenterol Nutr. 1995 Nov;21(4):383-6.</citation>
    <PMID>8583288</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2012</study_first_submitted>
  <study_first_submitted_qc>December 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2012</study_first_posted>
  <last_update_submitted>April 15, 2018</last_update_submitted>
  <last_update_submitted_qc>April 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Maryland</investigator_affiliation>
    <investigator_full_name>Rose Viscardi</investigator_full_name>
    <investigator_title>University of Maryland</investigator_title>
  </responsible_party>
  <keyword>intestinal permeability</keyword>
  <keyword>preterm infants</keyword>
  <keyword>dual sugar test</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Lactulose</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

